This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Example content

Adverse event reporting can be found at the bottom of the page

 




Protecting our planet: 

together we can make a difference

Future generations will look back on the first half of the 21st century as a critical moment in the history of our planet.

It’s clear that we all have a responsibility, right now, to meet the immense challenges posed by climate change. Pfizer, like the NHS, is determined to play its part.
 

We have taken decisive action to drive our business towards challenging sustainability goals. We know that by working together we can achieve so much more, so we are making it clear that we expect similarly high standards of our suppliers. 

 

A picture containing clipart

Description automatically generatedThe need to reduce Greenhouse Gas (GHG) emissions is of critical global importance, and Pfizer is supporting the drive for Net Zero – defined by the United Nations as cutting greenhouse gas emissions to as close to zero as possible, with any remaining emissions re-absorbed from the atmosphere.1


A voluntary Net Zero Standard, launched by the Science Based Targets initiative in 2021, requires companies to set long-term science-based targets to cut all possible emissions before 2050, and most companies must reduce emissions by more than 90%. It also states that permanent carbon removal and storage must be used to counterbalance the final <10% of residual emissions that cannot be eliminated.2


The UK Government has set a Net Zero target for all its health services3 - NHS England, for example, has declared a bold aim to be the world’s first Net Zero national health service.4 Pfizer stands shoulder-to-shoulder with this level of ambition by committing to meeting the Net Zero Standard by 2040 ten years ahead of the requirement.5 We are asking suppliers to follow our lead.

 

Our commitment builds on more than 20 years of environmental action, realising greater than a 60% reduction in company (Scope 1 & 2*) emissions from 2000 to 2020.6

For us, this links directly to our company purpose – breakthroughs that change patients’ lives – by recognising that taking decisive action to protect our environment will benefit all of us, individually and as a society.

Landmark events such as Earth Day offer important moments to reflect on what we have committed to achieve, and how much more we can do. We are determined to work with the NHS, and with all our partners and suppliers, to develop a truly collective effort and to establish momentum. We all need to be bold, seize the moment, and achieve the results that the next generation depend on us to deliver.


Pfizer's approach to Environment, Social & Governance (ESG):
 

Our commitment to advancing sustainability priorities is embedded into key elements of Pfizer’s business and decision-making. It guides our actions and enables us to enhance our performance by:

  1. prioritising the health and well-being of society and the environment
  2. driving investment in our people
  3. upholding high ethical standards in the ways we do business

 

Download this overview of our commitment to a sustainable future.
 

DownloadLoading
Impact of Medicines

Innovation is what we do at Pfizer – it’s key to our success – so we are applying this focus to reduce the environmental impact of our medicines throughout their lifecycle. We are seeking new ways to conserve energy, reduce water and raw materials usage, drive out waste and embrace ‘circular solutions’ (where possible, sharing, leasing, reusing, repairing, refurbishing and recycling existing materials8). Through lifecycle assessments (LCAs) for small molecules, large molecules, vaccines and devices, we identify actions which can have the most impact.9

Pfizer strives to remain a key NHS partner and we have a specialist team of healthcare account managers working to understand your current needs and priorities. We would welcome the opportunity to have a conversation and determine how we can best support you.

Contact the teamLoading
Scope 1 and 2 as defined by the GHG Protocol Corporate Standard:
  • Scope 1: Direct GHG emissions. Direct GHG emissions occur from sources that are owned or controlled by the company, for example, emissions from combustion in owned or controlled boilers, furnaces, vehicles, etc.; emissions from chemical production in owned or controlled process equipment.
  • Scope 2: Electricity indirect GHG emissions. GHG emissions from the generation of purchased electricity consumed by the company. Purchased electricity is defined as electricity that is purchased or otherwise brought into the organisational boundary of the company.7
United Nations. What is Net Zero? https://www.un.org/en/climatechange/net-zero-coalitionSBTi, Key components of the Corporate Net-Zero Standard https://sciencebasedtargets.org/net-zeroDoH press release, 9 Nov 2021 https://www.gov.uk/government/news/uk-health-services-make-landmark-pledge-to-achieve-net-zeroNHS England, Delivering a net zero NHS https://www.england.nhs.uk/greenernhs/a-net-zero-nhs/ESG report. Page 22, Climate Change https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/files/Pfizer_ESG_Report.pdfESG report. Page 80, Metrics & Targets https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/files/Pfizer_ESG_Report.pdf ESG Report, page 50, Environment https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/files/Pfizer_ESG_Report.pdfDefinition from European Parliament https://www.europarl.europa.eu/news/en/headlines/economy/20151201STO05603/circular-economy-definition-importance-and-benefitsESG Report, page 24, Sustainable Medicines https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2022/files/Pfizer_ESG_Report.pdf
PP-UNP-GBR-4613. April 2023

Here


Further reading:

Visit the featured articles page to read more
about some of the key topics in healthcare
at the moment. 

 

Read moreLoading

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​